2025 Breast Cancer Symposium
September 26, 2025 • 8:45 am to 4:30 pm
TIME | TOPIC |
---|---|
8:45 to 9:30 am |
Registration and Full Breakfast /Exhibitors |
9:30 to 9:40 am |
Welcome
Christopher Clarke, PhD |
Raymond C. Bergan, MD
|
|
9:40 to 10:40 am |
Session 1: A Better Therapy |
9:40 to 10:00 am |
MDC1, a New Target of Therapy-Induced Senescence and Chemosensitization in Breast Cancer Hyungjin Kim, PhD |
10:00 to 10:20 am |
Targeting Sphingolipid Metabolism to Protect Against Doxorubicin-Induced Cardiotoxicity Christopher Clarke, PhD |
10:20 to 10:40 am |
Micro-RNA-Strategies to Overcome Primary and Acquired Resistance to Mainstay Triple Negative Breast Cancer Treatments Jun Chung, PhD |
10:40 to 11:05 am |
Short Break and Meet with Exhibitors |
11:05 to 11:20 am |
Update on Breast Cancer Clinical TrialsAlison Stopeck, MD |
11:20 to 12:20 pm |
Keynote SpeakerTranslating Translational Regulation in Breast Cancer Metastasis Robert J. Schneider, PhD |
12:20 to 1:20 pm |
Lunch and Meet with Exhibitors |
1:20 to 2:20 pm | Session 2: A Better Image |
1:20 to 1:40 pm |
Artificial Intelligence for Personalizing Breast Cancer Screening and Addressing Health Disparities Cindy Lee, MD, FSBI, FACMQ, CMQ |
1:40 to 2:00 pm |
Contrast-enhanced Mammography for Determining Response to Anna Andrzejczyk, MD |
2:00 to 2:20 pm |
Single Cell Analysis of Blood-Brain Barrier in Response to General Anesthetics in Brain Metastasis of Breast Cancer Jun Lin, MD, PhD, FASA |
2:20 to 3:30 pm |
Poster Session |
3:20 to 3:30 pm |
Closing Remarks |
3:30 to 4:30 pm |
Social Networking |